Doppler, M.; Reincke, M.; Bettinger, D.; Vogt, K.; Weiss, J.; Schultheiss, M.; Uller, W.; Verloh, N.; Goetz, C.
Predictive Value of [99mTc]-MAA-Based Dosimetry in Hepatocellular Carcinoma Patients Treated with [90Y]-TARE: A Single-Center Experience. Diagnostics 2023, 13, 2432.
https://doi.org/10.3390/diagnostics13142432
AMA Style
Doppler M, Reincke M, Bettinger D, Vogt K, Weiss J, Schultheiss M, Uller W, Verloh N, Goetz C.
Predictive Value of [99mTc]-MAA-Based Dosimetry in Hepatocellular Carcinoma Patients Treated with [90Y]-TARE: A Single-Center Experience. Diagnostics. 2023; 13(14):2432.
https://doi.org/10.3390/diagnostics13142432
Chicago/Turabian Style
Doppler, Michael, Marlene Reincke, Dominik Bettinger, Katharina Vogt, Jakob Weiss, Michael Schultheiss, Wibke Uller, Niklas Verloh, and Christian Goetz.
2023. "Predictive Value of [99mTc]-MAA-Based Dosimetry in Hepatocellular Carcinoma Patients Treated with [90Y]-TARE: A Single-Center Experience" Diagnostics 13, no. 14: 2432.
https://doi.org/10.3390/diagnostics13142432
APA Style
Doppler, M., Reincke, M., Bettinger, D., Vogt, K., Weiss, J., Schultheiss, M., Uller, W., Verloh, N., & Goetz, C.
(2023). Predictive Value of [99mTc]-MAA-Based Dosimetry in Hepatocellular Carcinoma Patients Treated with [90Y]-TARE: A Single-Center Experience. Diagnostics, 13(14), 2432.
https://doi.org/10.3390/diagnostics13142432